Daxecker H, Raab M, Cichna M, Markl P, Müller M M
Institute of Laboratory Diagnostics and Ludwig Boltzmann Institute for Cardiothoracic Research, Kaiser Franz Josef Hospital, Kundratstrasse 3, A-1100, Vienna, Austria.
Clin Chim Acta. 2001 Aug 1;310(1):81-7. doi: 10.1016/s0009-8981(01)00526-5.
Immunosuppressive drugs are needed to prevent the rejection of transplanted organs by the immune system. Immunosuppressive antimetabolites act by interrupting cell metabolism. Their mechanism of action can be studied in vitro by measuring the inhibition of biochemical activities which is reflected by changes in the nucleotide content. In our experiments, human peripheral blood mononuclear cells (PBMC) isolated from healthy volunteers were used. After PBMC stimulation with phytohaemagglutinin (PHA) to mimic activation occurring at a rejection crisis, cells were exposed to varying concentrations of different immunosuppressants (i.e., mycophenolic acid, cyclosporin A and prednisolone) for 68 h at 37 degrees C. Changes in nucleotide content were observed by determining the concentrations of 15 nucleotides using a newly developed HPLC method. The results obtained for mycophenolic acid (MPA; final concentrations in a range between 0.1 and 5 micromol/l), cyclosporin A (CsA; final concentrations between 100 ng/ml and 1 microg/ml) and prednisolone (final concentrations between 0.5 and 10 micromol/l) are given as percentage changes in nucleotide content versus controls and are expressed as mean +/- confidence interval. The possibility of synergistic effects was investigated by incubating the cells with mixtures of all three immunosuppressive drugs varying the amount of mycophenolic acid. In addition, we have shown the effects of MPA/guanosine co-incubation on the intracellular nucleotide levels. Stimulation of peripheral blood mononuclear cells with phytohaemagglutinin led to a significant increase of pyrimidine and purine nucleotides versus control values (100%). Pyrimidine (CTP, UDP, UTP) and purine nucleotides (GDP, GTP, ADP, ATP) were elevated up to 153+/-14% and 142+/-17%, respectively. Under co-incubation of cells with MPA, the GTP level decreased in a dose-related manner to 56+/-3% of control at a MPA final concentration of 5 micromol/l. Concomitantly, an increase of UTP values to 203+/-18% versus control was observed under co-incubation with 1 micromol/l MPA. Co-incubation of mononuclear cells with guanosine (50 micromol/l) compensated for the effects of MPA on intracellular GTP levels. Combination of MPA, CsA and prednisolone did not alter intracellular nucleotide profiles of PBMC compared to those under MPA incubation alone. The depletion of the guanine nucleotide pool and concomitant increase of uridine nucleotides under the influence of the immunosuppressive drug mycophenolic acid is caused by its inhibitory effects on the key enzyme of de novo purine biosynthesis, inosine 5'-monophosphate dehydrogenase (IMPDH).
需要使用免疫抑制药物来防止免疫系统对移植器官的排斥。免疫抑制抗代谢物通过中断细胞代谢发挥作用。其作用机制可通过测量生化活性的抑制来体外研究,这可通过核苷酸含量的变化反映出来。在我们的实验中,使用了从健康志愿者分离的人外周血单核细胞(PBMC)。在用植物血凝素(PHA)刺激PBMC以模拟排斥危机时发生的激活后,将细胞在37℃下暴露于不同浓度的不同免疫抑制剂(即霉酚酸、环孢素A和泼尼松龙)68小时。使用新开发的HPLC方法通过测定15种核苷酸的浓度来观察核苷酸含量的变化。霉酚酸(MPA;最终浓度在0.1至5微摩尔/升之间)、环孢素A(CsA;最终浓度在100纳克/毫升至1微克/毫升之间)和泼尼松龙(最终浓度在0.5至10微摩尔/升之间)的结果以核苷酸含量相对于对照的百分比变化给出,并表示为平均值±置信区间。通过将细胞与所有三种免疫抑制药物的混合物一起孵育,改变霉酚酸的量,研究了协同作用的可能性。此外,我们还展示了MPA/鸟苷共同孵育对细胞内核苷酸水平的影响。用植物血凝素刺激外周血单核细胞导致嘧啶和嘌呤核苷酸相对于对照值(100%)显著增加。嘧啶(CTP、UDP、UTP)和嘌呤核苷酸(GDP、GTP、ADP、ATP)分别升高至153±14%和142±17%。在细胞与MPA共同孵育时,在MPA最终浓度为5微摩尔/升时,GTP水平以剂量相关的方式降低至对照的56±3%。同时,在与1微摩尔/升MPA共同孵育时,观察到UTP值相对于对照增加至203±18%。单核细胞与鸟苷(50微摩尔/升)共同孵育可补偿MPA对细胞内GTP水平的影响。与单独MPA孵育相比,MPA、CsA和泼尼松龙的组合未改变PBMC的细胞内核苷酸谱。免疫抑制药物霉酚酸影响下鸟嘌呤核苷酸池的消耗和尿苷核苷酸的相应增加是由于其对嘌呤从头生物合成的关键酶肌苷5'-单磷酸脱氢酶(IMPDH)的抑制作用。